Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Adequate end-organ function
Adequate hematologic and end organ function based on laboratory results obtained within 14 days prior to initiation of study treatment;
Adequate hematologic and end-organ function, defined by laboratory test results, obtained within 14 days before initiation of study treatment
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function Cancer-Related Inclusion Criteria:
Adequate hematologic and end-organ function
Adequate hematologic and organ function
Adequate hematologic and end-organ function
Adequate hematologic and organ function within 28 days before the first study treatment
Adequate hematologic and end organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
The participant has adequate hematologic, organ, and coagulation function ?2 weeks (14 days) prior to first dose of study drug:
Adequate haematologic and end-organ function
Adequate hematologic and end-organ function
Have adequate hematologic, organ and coagulation function within 2 weeks (14 days) prior to enrollment.
Adequate hematologic and organ function
Adequate hematologic and end organ function obtained within 2 weeks prior to first dose of study drug
Adequate End organ function
Adequate hematologic and end organ function
Adequate end-organ function
Adequate end-organ function, as determined by laboratory tests obtained within 28 days prior to the first dose of study drug
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function.
Adequate hematologic and end organ function
Adequate hematologic and organ function within 28 days prior to initiation of study treatment
Adequate hematologic and end-organ function test results
Adequate hematologic and end organ function
Adequate hematologic and end organ function, confirmed by laboratory results obtained within 28 days prior to initiation of study drug
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function within 28 days prior to treatment initiation
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end organ function
Adequate hematologic and organ function within 14 days before the first study treatment
Adequate hematologic and end organ function, defined by the following laboratory results obtained within 14 days prior to the first study treatment (Cycle 1, Day 1):
Adequate hematologic and end organ function
Adequate hematologic and end organ function Cohort 2-Specific Inclusion Criteria
Have adequate organ and hematologic function, as determined by:
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Patients must have adequate hematologic and organ function.
Adequate hematologic and end organ function
Acceptable hematologic and organ function
Adequate hematologic and end organ function, defined by the following laboratory results obtained within 14 days prior to the first study treatment (Cycle 1, Day 1)
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and organ function within 14 days before the first study treatment
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Patients must have normal organ and hematologic function therapy
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and organ function within 14 days prior to treatment initiation
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end organ function
Adequate hematologic, cardiac, and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end-organ function
Adequate hematologic and end organ function
Adequate hematologic and end-organ function
